INBS fingerprint drug test achieves 94.1% accuracy; FDA submission on track for Q4 2024

INTELLIGENT BIO SOLUTIONS INC.

Method comparison study with 135 donors and 9 operators shows 94.1% accuracy, 82.2% sensitivity, 100% specificity for opiate detection.
FDA 510(k) submission expected in Q4 2024; includes data from PK study and method study.
System components evaluated: Drug Screening Cartridge, Reader, and Fingerprint Collection Kit.
CEO Harry Simeonidis states results reaffirm accuracy and reliability for workplace drug testing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.